|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Coronary Disease | |||||
| Tangier Disease | |||||
| Atherosclerosis | |||||
| 2 | More general conditions related to this trial | ||||
| Arterial Occlusive Diseases | |||||
| Arteriosclerosis | |||||
| Dyslipidemias | |||||
| Genetic Diseases, Inborn | |||||
| Hypoalphalipoproteinemias | |||||
| Hypolipoproteinemias | |||||
| Lipid Metabolism Disorders | |||||
| Lipid Metabolism, Inborn Errors | |||||
| Metabolic Diseases | |||||
| Metabolism, Inborn Errors | |||||
| Myocardial Ischemia | |||||
| Nervous System Diseases | |||||
| Neuromuscular Diseases | |||||
| Peripheral Nervous System Diseases | |||||
| Polyneuropathies | |||||
| Vascular Diseases | |||||
| 3 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||